Related Experiment Video
Updated: Mar 21, 2026

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
Published on: October 15, 2014
TORC2 Structure and Function
Christl Gaubitz1, Manoel Prouteau1, Beata Kusmider1
1Department of Molecular Biology, and Institute of Genetics and Genomics of Geneva (iGE3), University of Geneva, 30 quai Ernest Ansermet, CH1211 Geneva, Switzerland.
Abstract:
The target of rapamycin (TOR) kinase functions in two multiprotein complexes, TORC1 and TORC2. Although both complexes are evolutionarily conserved, only TORC1 is acutely inhibited by rapamycin. Consequently, only TORC1 signaling is relatively well understood; and, at present, only mammalian TORC1 is a validated drug target, pursued in immunosuppression and oncology. However, the knowledge void surrounding TORC2 is dissipating. Acute inhibition of TORC2 with small molecules is now possible and structural studies of both TORC1 and TORC2 have recently been reported. Here we review these recent advances as well as observations made from tissue-specific mTORC2 knockout mice. Together these studies help define TORC2 structure-function relationships and suggest that mammalian TORC2 may one day also become a bona fide clinical target.
Insights
Recent advances illuminate the target of rapamycin complex 2 (TORC2) signaling pathway. New insights into TORC2 structure and function suggest its potential as a future clinical drug target.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Signaling
Background:
- The target of rapamycin (TOR) kinase exists in two complexes: TORC1 and TORC2.
- TORC1 signaling is well-understood and is a validated drug target for immunosuppression and oncology.
- TORC2 signaling has remained less understood, with limited knowledge of its function and therapeutic potential.
Purpose of the Study:
- To review recent advances in understanding TORC2 structure and function.
- To explore the emerging potential of TORC2 as a clinical drug target.
Main Methods:
- Review of recent structural studies of TORC1 and TORC2.
- Analysis of data from tissue-specific mTORC2 knockout mice.
- Discussion of novel small molecules enabling acute TORC2 inhibition.
Main Results:
- Acute inhibition of TORC2 is now achievable with small molecules.
- Recent structural studies have provided new insights into both TORC1 and TORC2.
- Studies using knockout mice have helped define TORC2 structure-function relationships.
Conclusions:
- The knowledge gap regarding TORC2 is rapidly closing.
- Mammalian TORC2 is emerging as a potential future therapeutic target.
- Further research into TORC2 may yield new treatments for various diseases.
Related Concept Videos
ATP Synthase: Structure
Cytoskeletal Accessory Proteins
Overview of Myosin Structure and Function
Structural Protein Function
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

